Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality 
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Oil Prices Slip as U.S.-Iran Talks Ease Middle East Tensions 
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out 
Altria Group Inc., an American tobacco company that is one of the largest producers of cigarettes and related products in the world, is buying NJOY e-cigarette and vaping startup for almost $2.8 billion.
Altria also holds the rights to the Marlboro cigarette brand in the United States, and on Monday this week, it announced its agreement to acquire NJOY. This comes after the company lost billions when it invested in another e-cigarette company, Juul.
As per Reuters, a number of major tobacco companies have recently been investing heavily in cigarette alternatives as the smoking rates around the world continue to fall. Although the e-cigarette and vaping are also facing tough regulatory scrutiny as many minors are getting into the habit of “smoking,” Altria is still pushing through with the cigarette alternative business.
It was reported that Altria is betting that NJOY will provide it with an easier way to push into the market since six of its products have already received full approval from the U.S. Food and Drug Administration (USFDA).
On the other hand, Juul is still in the middle of seeking the same approval for its e-cigarette line. It is having difficulties with the process after it was criticized for its threat to health and use by minors.
To fund the deal with NJOY, Altria will use cash from a $2.7 billion agreement it had with Philip Morris International last year for its IQOS heated tobacco line. It was said that the contract with NJOY would include an additional $500 million in cash payments as per the regulatory approvals of its other products.
“We believe we can responsibly accelerate U.S. adult smoker and competitive adult vaper adoption of NJOY ACE in ways that NJOY could not as a standalone company,” Altria’s chief executive officer, Billy Gifford, said in a press release. “We believe the strengths of our commercial resources can benefit adult tobacco consumers and expand competition. We are also excited to welcome NJOY's talented employees to Altria at closing.”
Photo by: Brendan Stephens/Unsplash
